Dr. Sameer Rana completed his studies in Biomedical Sciences and Medicine at the University of Amsterdam. He subsequently conducted PhD research at the University of Amsterdam (Amsterdam UMC, AMC), the University of California, San Francisco (USA), and completed a fellowship at Stanford University (USA), with a specific focus on stem cell biology, regenerative medicine, and molecular therapies. He gained clinical experience in surgery and conducted clinical trials involving injectables for the treatment of arthritis and pain. Dr. Rana has also passed the USMLE exams to become a certified physician in the United States (ECFMG certified) and has been trained internationally, with programs completed in the United States, Italy, and the United Arab Emirates, among others.
Dr. Rana specializes in skin rejuvenation and restoration technologies through the use of injectables, laser treatments, autologous fat grafting, and surgical procedures. He holds certifications in Aesthetic Medicine and Aesthetic Surgery, awarded by institutions including the American Academy of Aesthetic and Regenerative Medicine. He places great importance on education and stays current with the latest treatment methods by participating in continuing education, training programs, and attending (inter)national conferences.
Dr. Sameer Rana is committed to open and transparent communication and places strong emphasis on understanding the wishes and expectations of his patients, in order to achieve the best possible treatment outcomes.
Specialization/areas of interest
Aesthetic Medicine
Languages
Dutch, English, Urdu
Work experience
2025-heden: Aesthetic Physician, freelance at various clinics
2021-2025: Aesthetic Physician, Clinic63, NL
2020-2021: Medical Doctor, at various health centers/clinics
2019-2020: Clinical Researcher Regenerative Medicine & Orthobiologics, Stanford University, CA, USA
2017-2018: Fellowship Tissue Engineering & Regenerative Medicine, Stanford University, CA, USA
2016: Medical Doctor UMCU
2013-2015: Research Scientist, Amsterdam UMC, AMC
2008-2013: PhD Candidate, Amsterdam UMC, AMC; UCSF, CA, USA
Education
2022-2023: Board certification Aesthetic and Regenerative Medicine, AAARM, Dubai, UAE
2015: Doctor of Medicine, University of Amsterdam
2014: Doctor of Philosophy, Medicine, University of Amsterdam
2008: Master of Science, Medicine, University of Amsterdam
2008: Master of Science, Biomedical Sciences, University of Amsterdam
Thesis
M.S. Rana, Molecular and genetic basis of congenital conotruncal heart defects, maart 2014.
Medical Publications
● Roh EY, Rana MS, McInnis KC, Bakal DR, Borgstrom H, Borg-Stein J. Orthobiologic injectables in the ankle joint: a narrative review. MLTJ. 2022; 12 (4): 453-477. doi: 10.32098/mltj.04.2022.01
● Rana MS, Théveniau-Ruissy M, De Bono C, Mesbah K, Francou A, Rammah M, Domínguez JN, Roux M, Laforest B, Anderson RH, Mohun T, Zaffran S, Christoffels VM, Kelly RG. Tbx1 coordinates addition of posterior second heart field progenitor cells to the arterial and venous poles of the heart. Circ Res. 2014 Oct 10;115(9):790-9. doi: 10.1161/CIRCRESAHA.115.305020. Epub 2014 Sep 4. PMID: 25190705.
● Rana MS, Sizarov A, Christoffels VM, Moorman AF. Development of the human aortic arch system captured in an interactive three-dimensional reference model. Am J Med Genet A. 2014 Jun;164A(6):1372-83. doi: 10.1002/ajmg.a.35881. Epub 2013 Apr 23. PMID: 23613216.
● Rana MS, Christoffels VM, Moorman AF. A molecular and genetic outline of cardiac morphogenesis. Acta Physiol (Oxf). 2013 Apr;207(4):588-615. doi: 10.1111/apha.12061. Epub 2013 Feb 1. PMID: 23297764.
● Spruijt NE, Rana MS, Christoffels VM, Mink van der Molen AB. Exploring a neurogenic basis of velopharyngeal dysfunction in Tbx1 mutant mice: no difference in volumes of the nucleus ambiguus. Int J Pediatr Otorhinolaryngol. 2013 Jun;77(6):1002-7. doi: 10.1016/j.ijporl.2013.03.032. Epub 2013 May 1. PMID: 23642587.
● Francou A, Saint-Michel E, Mesbah K, Théveniau-Ruissy M, Rana MS, Christoffels VM, Kelly RG. Second heart field cardiac progenitor cells in the early mouse embryo. Biochim Biophys Acta. 2013 Apr;1833(4):795-8. doi: 10.1016/j.bbamcr.2012.10.003. Epub 2012 Oct 7. PMID: 23051926.
● Mesbah K, Rana MS, Francou A, van Duijvenboden K, Papaioannou VE, Moorman AF, Kelly RG, Christoffels VM. Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis. Hum Mol Genet. 2012 Mar 15;21(6):1217-29. doi: 10.1093/hmg/ddr553. Epub 2011 Nov 24. PMID: 22116936; PMCID: PMC3491916.
● Singh R, Hoogaars WM, Barnett P, Grieskamp T, Rana MS, Buermans H, Farin HF, Petry M, Heallen T, Martin JF, Moorman AF, ‘t Hoen PA, Kispert A, Christoffels VM. Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation. Cell Mol Life Sci. 2012 Apr;69(8):1377-89. doi: 10.1007/s00018-011-0884-2. Epub 2011 Dec 1. PMID: 22130515; PMCID: PMC3314179.
● Aanhaanen WT, Brons JF, Domínguez JN, Rana MS, Norden J, Airik R, Wakker V, de Gier-de Vries C, Brown NA, Kispert A, Moorman AF, Christoffels VM. The Tbx2+ primary myocardium of the atrioventricular canal forms the atrioventricular node and the base of the left ventricle. Circ Res. 2009 Jun 5;104(11):1267-74. doi: 10.1161/CIRCRESAHA.108.192450. Epub 2009 May 7. PMID: 19423846.
● Rana MS, Horsten NC, Tesink-Taekema S, Lamers WH, Moorman AF, van den Hoff MJ. Trabeculated right ventricular free wall in the chicken heart forms by ventricularization of the myocardium initially forming the outflow tract. Circ Res. 2007 Apr 13;100(7):1000-7. doi: 10.1161/01.RES.0000262688.14288.b8. Epub 2007 Mar 8. PMID: 17347476.
